Description |
Sophoraflavanone G (Kushenol F) is iaolated from Sophora flavescens and shows anti-tumor and anti-inflammatory properties. Sophoraflavanone G (Kushenol F) induces MDA-MB-231 and HL-60 cells apoptosis through suppression of MAPK-related pathways[1][2].
|
Target |
IC50: 29.7 μM (MDA-MB-231 cell)[1]
|
In Vitro |
Sophoraflavanone G (0 -100 μM; 24 hours) decreases the viability of the HL-60 cells in a dose-dependent manner[1]. Sophoraflavanone G (0 -100 μM; 24 hours) induces HL-60 cell apoptosis, activated caspase-3 and caspase-9, and downregulated Bcl-2 and Bcl-xL. It also upregulates Bax and released cytochrome c from the mitochondria into the cytoplasm, enabling apoptosis via the mitochondrially-mediated "intrinsic" pathway[1] Sophoraflavanone G (0 -40 μM; 24 hours) inhibits MDA-MB-231 cell viability in a concentration-dependent manner, with an IC50 value of 29.7 ± 5.2 μM[2]<.br>
|
Density | 1.3±0.1 g/cm3 |
Boiling Point | 659.3±55.0 °C at 760 mmHg |
Flash Point | 224.8±25.0 °C |
Exact Mass | 424.188599 |
PSA | 107.22000 |
LogP | 6.52 |
Vapour Pressure | 0.0±2.1 mmHg at 25°C |
Storage condition | 2-8℃ |